TR199901961T2 - Amoksosilin ve klav�lanat i�eren ispen�iyariler. - Google Patents

Amoksosilin ve klav�lanat i�eren ispen�iyariler.

Info

Publication number
TR199901961T2
TR199901961T2 TR1999/01961T TR9901961T TR199901961T2 TR 199901961 T2 TR199901961 T2 TR 199901961T2 TR 1999/01961 T TR1999/01961 T TR 1999/01961T TR 9901961 T TR9901961 T TR 9901961T TR 199901961 T2 TR199901961 T2 TR 199901961T2
Authority
TR
Turkey
Prior art keywords
clavulanate
amoxocillin
pharmaceuticals containing
formulations
potassium clavulanate
Prior art date
Application number
TR1999/01961T
Other languages
English (en)
Turkish (tr)
Inventor
Andre Gustave Mention Jacky
Luis Sanroma Bordallo Jose
Storm Kevin
Original Assignee
Smith Kline Beecham Laboratoires Pharmaceutiques
Smithkline Beecham S.A.
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9703100.9A external-priority patent/GB9703100D0/en
Priority claimed from GBGB9703101.7A external-priority patent/GB9703101D0/en
Priority claimed from GBGB9703099.3A external-priority patent/GB9703099D0/en
Application filed by Smith Kline Beecham Laboratoires Pharmaceutiques, Smithkline Beecham S.A., Smithkline Beecham Corporation filed Critical Smith Kline Beecham Laboratoires Pharmaceutiques
Publication of TR199901961T2 publication Critical patent/TR199901961T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
TR1999/01961T 1997-02-14 1998-02-10 Amoksosilin ve klav�lanat i�eren ispen�iyariler. TR199901961T2 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9703100.9A GB9703100D0 (en) 1997-02-14 1997-02-14 Formulations
GBGB9703101.7A GB9703101D0 (en) 1997-02-14 1997-02-14 Formulations
GBGB9703099.3A GB9703099D0 (en) 1997-02-14 1997-02-14 Formulations

Publications (1)

Publication Number Publication Date
TR199901961T2 true TR199901961T2 (xx) 1999-11-22

Family

ID=27268719

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01961T TR199901961T2 (xx) 1997-02-14 1998-02-10 Amoksosilin ve klav�lanat i�eren ispen�iyariler.

Country Status (25)

Country Link
EP (2) EP1142574A1 (https=)
JP (1) JP2001512451A (https=)
KR (1) KR100499812B1 (https=)
CN (1) CN1194687C (https=)
AP (1) AP1253A (https=)
AT (1) ATE243516T1 (https=)
AU (1) AU728526B2 (https=)
BG (1) BG103664A (https=)
BR (1) BR9807383A (https=)
CA (1) CA2280857A1 (https=)
DE (1) DE69815833T2 (https=)
DZ (1) DZ2420A1 (https=)
EA (1) EA002595B1 (https=)
ES (1) ES2201468T3 (https=)
HK (1) HK1043041A1 (https=)
ID (1) ID23673A (https=)
IL (1) IL131201A (https=)
MA (1) MA24473A1 (https=)
NO (1) NO993887L (https=)
NZ (1) NZ337043A (https=)
OA (1) OA11087A (https=)
PL (1) PL334976A1 (https=)
SK (1) SK110299A3 (https=)
TR (1) TR199901961T2 (https=)
WO (1) WO1998035672A1 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
AR004510A1 (es) 1995-09-07 1998-12-16 Smithkline Beecham Plc Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
AU2869100A (en) * 1999-02-26 2000-09-14 Biovail International Ltd. Storage stable amoxycillin and clavulanate suspension composition
AP1806A (en) * 1999-04-13 2007-12-14 Beecham Pharmaceuticals Pte Ltd The use of a high dosage regimen of amoxycillin and potassium chavulate for the treatment of bacterial infections.
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
FR2797588B1 (fr) * 1999-08-20 2003-08-01 Smithkline Beecham Lab Formulation pharmaceutique a base d'amoxycilline et de clavulanate
WO2001013883A1 (en) * 1999-08-20 2001-03-01 Smithkline Beecham Laboratoires Pharmaceutiques S.A.S. Pharmaceutical formulation comprising amoxycillin and clavulanate
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
AU2003208358A1 (en) * 2002-02-01 2003-09-02 Sandoz Gmbh Demixing-stable granulate
JP4698950B2 (ja) * 2002-04-09 2011-06-08 フラメル・テクノロジー アモキシシリンの改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
WO2004006917A1 (en) * 2002-07-16 2004-01-22 Ranbaxy Laboratories Limited Dispersible tablets for oral administration
CA2529102A1 (en) * 2003-06-16 2004-12-23 Glaxo Group Limited Pharmaceutical formulations comprising amoxicillin and clavulanate
KR100676617B1 (ko) * 2004-06-18 2007-01-30 주식회사유한양행 아목시실린 및/또는 클라불란산 또는 이의 염을 함유하는경구용 현탁정제 조성물
SI21912A (sl) * 2004-12-24 2006-06-30 Lek Farmacevtska Druzba D.D. Stabilne farmacevtske oblike, ki vsebujejo amoksicilin in klavulansko kislino
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CN100464750C (zh) * 2006-02-23 2009-03-04 珠海联邦制药股份有限公司 一种制备含阿莫西林钠和克拉维酸钾的药物混合物的方法
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20070521A7 (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
FI20080352A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
WO2009135946A1 (en) 2008-05-09 2009-11-12 Atacama Labs Oy Method and apparatus for dry granulation
CN102861015B (zh) * 2011-07-05 2015-07-08 北京乐维生物技术有限公司 一种稳定的阿莫西林克拉维酸钾缓释制剂及其制备工艺
WO2014065769A1 (en) * 2012-10-22 2014-05-01 Bilgiç Mahmut Formulations for oral suspensions comprising antibiotics
CN105555261B (zh) * 2013-09-20 2020-02-11 灿盛制药有限公司荷兰公司 包含交聚维酮的片剂
US9254261B2 (en) * 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
KR102002906B1 (ko) * 2016-10-18 2019-07-23 경동제약 주식회사 셀레콕시브를 포함하는 정제
CN114072493A (zh) 2019-07-05 2022-02-18 葛兰素史密斯克莱知识产权（第2 号）有限公司 棒状链霉菌
CN113274357B (zh) * 2021-05-28 2022-12-27 广州白云山医药集团股份有限公司白云山制药总厂 一种阿莫西林药物及其制备方法
CN114869884A (zh) * 2021-07-30 2022-08-09 江苏恒丰强生物技术有限公司 一种用于猪呼吸道疾病的复方阿莫西林粉及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
AU5863894A (en) * 1993-01-22 1994-08-15 Smithkline Beecham Plc Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ1926A1 (fr) * 1994-09-03 2002-02-17 Smithkline Beckman P L C Formulations pharmaceutiques.

Also Published As

Publication number Publication date
KR100499812B1 (ko) 2005-07-08
NO993887D0 (no) 1999-08-12
WO1998035672A1 (en) 1998-08-20
EP0975342B1 (en) 2003-06-25
EP0975342A1 (en) 2000-02-02
CN1251990A (zh) 2000-05-03
ID23673A (id) 2000-05-11
EP1142574A1 (en) 2001-10-10
ES2201468T3 (es) 2004-03-16
MA24473A1 (fr) 1998-10-01
IL131201A0 (en) 2001-01-28
EA199900647A1 (ru) 2000-06-26
CN1194687C (zh) 2005-03-30
BR9807383A (pt) 2000-03-14
JP2001512451A (ja) 2001-08-21
ATE243516T1 (de) 2003-07-15
NZ337043A (en) 2001-02-23
NO993887L (no) 1999-08-12
AU6719698A (en) 1998-09-08
HK1043041A1 (en) 2002-09-06
OA11087A (en) 2003-03-13
DE69815833T2 (de) 2004-05-19
DZ2420A1 (fr) 2003-01-04
SK110299A3 (en) 2000-08-14
DE69815833D1 (de) 2003-07-31
AU728526B2 (en) 2001-01-11
AP9901623A0 (en) 1999-09-30
BG103664A (en) 2000-03-31
EA002595B1 (ru) 2002-06-27
AP1253A (en) 2004-03-17
KR20000071076A (ko) 2000-11-25
CA2280857A1 (en) 1998-08-20
PL334976A1 (en) 2000-03-27
IL131201A (en) 2005-06-19

Similar Documents

Publication Publication Date Title
TR199901961T2 (xx) Amoksosilin ve klav�lanat i�eren ispen�iyariler.
DE69617236D1 (de) N-heteroaryl-pyridinsulfonamidderivate und deren verwendung als endothelinantagonisten
TR200000152T2 (tr) Yeni bileşikler.
TR200200982T2 (tr) Farmasötik bileşim terkipleri.
CA2135277A1 (en) Anti-receptor agents to the vitamin b12/transcobalamin ii receptor
DE69405729D1 (de) 1,4-benzoxazinderivate als kalium kanalaktivatoren
BR9307245A (pt) Conjunto de mancal fechado com rolete selado
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
FR2708434B1 (fr) Mallette à plusieurs modes de transport, notamment pour écolier.
TR199800714T2 (xx) Yeni $(3-Alkoksi-fenoksi)-etil]-dialkilamin t�revleri.
DE59205917D1 (de) Treibmittel für aerosole und dosieraerosole
TR199801612T2 (xx) Benzotiofen, benzotiofen i�eren form�ller ve y�ntemler.
PT78289A (en) (1h-tetrazol-5-yl)2(1h)-quinolines and related compounds
FR2740680B1 (fr) Composition cosmetique solide et utilisations
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
TR200001135T2 (tr) Dofetilid polimorfları.
DE4393754T1 (de) Ladungskontrollmittel-Zusammensetzung und Toner, welcher diese enthält
NO985079L (no) Eksplosiv formulering
DE3676632D1 (de) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
TR28882A (tr) Yeni 1,3-oxazin-4-one türevleri, ayni maddeyi iceren herbisidler ve ayni maddenin hazirlanmasinda kullanilan ara ürünler.
AU580890B2 (en) P-acylaminobenzamides
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
NO985111L (no) Eksplosiv formulering
DE59609913D1 (de) Piperidinylmethyloxazolidin-2-on Derivate, deren Herstellung und deren Verwendung als ZNS wirksame Verbindungen
NO985110L (no) Eksplosivformuleringer